NASDAQ : IRON
Disc Medicine, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 82.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.60B |
| Enterprise Value | 2.94B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 44.39M |
| Shares Outstanding | 44.39M |
| Shares Change (YoY) | +16.89% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 95.04% |
| Float | 38.99M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 4,306.48 |
| PB Ratio | 4.81 |
| P/TBV Ratio | 5.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 24.14 |
| Quick Ratio | 23.64 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -75.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -39.08% |
| Return on Assets (ROA) | -23.96% |
| Return on Invested Capital (ROIC) | -24.85% |
| Return on Capital Employed (ROCE) | -38.09% |
| Weighted Average Cost of Capital (WACC) | 15.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.49M |
| Employee Count | 165 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 310,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -4.89% |
| 50-Day Moving Average | 71.37 |
| 200-Day Moving Average | 70.68 |
| Relative Strength Index (RSI) | 64.80 |
| Average Volume (20 Days) | 1,549,798 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.46M |
| Short Previous Month | 7.27M |
| Short % of Shares Out | 16.80% |
| Short % of Float | 19.13% |
| Short Ratio (days to cover) | 11.60 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -268.41M |
| Pretax Income | -245.58M |
| Net Income | -245.89M |
| EBITDA | -268.06M |
| EBIT | -268.41M |
| Earnings Per Share (EPS) | -$6.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 717.75M |
| Total Debt | 60.86M |
| Net Cash | 656.88M |
| Net Cash Per Share | $14.80 |
| Equity (Book Value) | 644.16M |
| Book Value Per Share | 16.80 |
| Working Capital | 702.40M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -197.54M |
| Capital Expenditures | -46,000 |
| Depreciation & Amortization | 355,000 |
| Net Borrowing | 29.98M |
| Free Cash Flow | -197.58M |
| FCF Per Share | -$4.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -16.89% |
| Shareholder Yield | -16.89% |
| Earnings Yield | -8.09% |
| FCF Yield | -5.51% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $125.75 |
| Price Target Difference | 55.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |